These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3139949)

  • 1. Rapid induction of lorazepam dependence and reversal with flumazenil.
    Nutt DJ; Costello MJ
    Life Sci; 1988; 43(13):1045-53. PubMed ID: 3139949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of alcohol dependence and tolerance by a single administration of flumazenil.
    Buck KJ; Heim H; Harris RA
    J Pharmacol Exp Ther; 1991 Jun; 257(3):984-9. PubMed ID: 1646333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice and rats are sensitized to the proconvulsant action of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam.
    Lister RG; Nutt DJ
    Brain Res; 1986 Aug; 379(2):364-6. PubMed ID: 3017512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flumazenil and benzodiazepine withdrawal.
    Lancet; 1987 Aug; 2(8556):463. PubMed ID: 2887772
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines.
    Cumin R; Bonetti EP; Scherschlicht R; Haefely WE
    Experientia; 1982 Jul; 38(7):833-4. PubMed ID: 6809488
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic treatment with lorazepam and FG 7142 may change the effects of benzodiazepine receptor agonists, antagonists and inverse agonists by different mechanisms.
    Petersen EN; Jensen LH
    Eur J Pharmacol; 1987 Jan; 133(3):309-17. PubMed ID: 3030777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
    Allan AM; Baier LD; Zhang X
    J Pharmacol Exp Ther; 1992 May; 261(2):395-402. PubMed ID: 1374467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.
    Griffiths RR; Evans SM; Guarino JJ; Roache JD; Furman WR; Liebson I; Schwam EM
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1163-74. PubMed ID: 8510001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
    Martin WR; Sloan JW; Wala E
    J Pharmacol Exp Ther; 1990 Nov; 255(2):744-55. PubMed ID: 1978731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal.
    Gerra G; Giucasto G; Zaimovic A; Fertonani G; Chittolini B; Avanzini P; Caccavari R; Delsignore R
    Int Clin Psychopharmacol; 1996 Jun; 11(2):81-8. PubMed ID: 8803645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical dependence on diazepam in the dog: precipitation of different abstinence syndromes by the benzodiazepine receptor antagonists Ro 15-1788 and ZK 93426.
    Löscher W; Hönack D; Fassbender CP
    Br J Pharmacol; 1989 Jul; 97(3):843-52. PubMed ID: 2569347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice.
    Piot O; Betschart J; Stutzmann JM; Blanchard JC
    Neurosci Lett; 1990 Sep; 117(1-2):140-3. PubMed ID: 2290609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases.
    Faccini M; Leone R; Opri S; Casari R; Resentera C; Morbioli L; Conforti A; Lugoboni F
    J Psychopharmacol; 2016 Oct; 30(10):1047-53. PubMed ID: 27166362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous flumazenil infusion to treat benzodiazepine dependence should be performed in the inpatient clinical setting for high risk of seizure.
    Lugoboni F; Faccini M; Quaglio GL; Albiero A; Casari R; Pajusco B
    J Psychopharmacol; 2011 Jun; 25(6):848-9. PubMed ID: 21262854
    [No Abstract]   [Full Text] [Related]  

  • 16. Flumazenil reversal of benzodiazepine sedation before electroconvulsive therapy.
    Hanania MM
    Anesthesiology; 1995 Jan; 82(1):321. PubMed ID: 7832328
    [No Abstract]   [Full Text] [Related]  

  • 17. Low tolerance and dependence liabilities of etizolam: molecular, functional, and pharmacological correlates.
    Sanna E; Busonero F; Talani G; Mostallino MC; Mura ML; Pisu MG; Maciocco E; Serra M; Biggio G
    Eur J Pharmacol; 2005 Sep; 519(1-2):31-42. PubMed ID: 16107249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation.
    Koff JM; Pritchard GA; Greenblatt DJ; Miller LG
    Pharmacology; 1997 Nov; 55(5):217-27. PubMed ID: 9399331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice.
    Raghavendra V; Kulkarni SK
    Eur J Pharmacol; 2000 Dec; 409(3):279-89. PubMed ID: 11108822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flumazenil reversal of benzodiazepine-induced sedation for a patient with severe pre-ECT anxiety.
    Bailine SH; Safferman A; Vital-Herne J; Bernstein S
    Convuls Ther; 1994 Mar; 10(1):65-8. PubMed ID: 7914463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.